Earth Science Tech Inc. (OTC: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, has completed the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products. The acquisition, which was announced recently, marks a significant step in ETST's strategy to diversify its revenue streams and strengthen its position in the healthcare supply chain.
Zoolzy, based in Doral, Florida, operates from a 3,684-square-foot facility and specializes in the distribution of APIs and finished pharmaceutical products. By integrating Zoolzy into its operations, ETST aims to leverage the acquisition to drive growth across three key areas: expanding profit margins, broadening access to new ingredients, and entering the veterinary market. The move is expected to complement ETST's existing compounding pharmacies by providing them with direct access to essential raw materials at competitive wholesale prices, thereby reducing costs and increasing overall profitability.
The acquisition underscores ETST's commitment to seizing strategic opportunities that enhance its telehealth and pharmacy fulfillment platforms. By adding Zoolzy's distribution capabilities, ETST can now offer a wider range of products and services, including those tailored to the veterinary sector. This vertical integration is likely to improve supply chain efficiency and create new revenue streams, positioning the company for sustained growth in the competitive healthcare market.
For more information on this development, visit the company's newsroom at https://ibn.fm/ETST.
This acquisition is part of ETST's broader strategy to build a comprehensive healthcare ecosystem that leverages technology and distribution to meet the evolving needs of patients and providers. The company's focus on compounding pharmacies and telemedicine aligns with the growing demand for personalized and accessible healthcare solutions.
Investors and industry observers will be watching to see how ETST integrates Zoolzy's operations and whether the anticipated synergies materialize. The move signals ETST's confidence in the growth potential of the pharmaceutical distribution sector and its ability to execute on strategic acquisitions.
For additional details on the acquisition, refer to the source release at https://ibn.fm/vcqkE.
